CAR-T cells derived from multiple myeloma patients at diagnosis have improved cytotoxic functions compared to those produced at relapse or following daratumumab treatment. - Abecassis A; Roders N; Fayon M; Choisy C; Nelson E; Harel S; Royer B; Villesuzanne C; Talbot A; Garrick D; Goodhardt M; Fermand JP; et al. (EJHaem, 2022)